Abstract

Acephalic spermatozoa is a very rare disorder of male infertility. Here, in a patient from from a consanguineous family, we have identified, by whole-exome sequencing, a homozygous mutation (c.G2783A, p.G928D) in the BRDT gene. The gene product, BRDT, is a testis-specific protein that is considered an important drug target for male contraception. The G928D mutation is in the P-TEFb binding domain, which mediates the interaction with transcription elongation factor and might affect the transcriptional activities of downstream genes. By RNA-sequencing analysis of cells expressing the BRDT mutation, we found the p.G928D mutation protein causes mis-regulation of 899 genes compared with BRDT wild-type cells. Furthermore, by Gene Ontology analysis, the upregulated genes in p.G928D cells were enriched in the processes of intracellular transport, RNA splicing, cell cycle and DNA metabolic process, revealing the underlying mechanism of the pathology that leads to acephalic spermatozoa.

Highlights

  • Annotation NM_014272:exon21:c.G4496A:p.R1499Q, NM_019032:exon17:c.G2839A:p.V947M, NM_005745:exon2:c.T53C:p.V18A, NM_207189:exon19:c.G2783A:p.G928D, NM_004009:exon17:c.C2084G:p.A695G, NM_144618:exon6:c.C701T:p.A234V, NM_015635:exon19:c.G3232A:p.A1078T, NM_001195256:exon1:c.C67T:p.P23S, NM_014520:exon1:c.T104C:p.F35S, NM_006213:exon8:c.C773T:p.S258L, NM_003557:exon1:c.C68A:p.S23Y, NM_006598:exon19:c.C2498T:p.S833L, NM_178505:exon1:c.G25T:p.A9S, NM_000743:exon5:c.C1112T:p.P371L, NM_001161808:exon7:c.G1301A:p.R434H, NM_025130:exon14:c.A1984C:p.M662L, Supplementary Table 2: DNA Primers used in this study

  • Goat Anti-Rabbit IgG (H+L) Goat Anti-Mouse IgG (H+L)

Read more

Summary

Introduction

Whole-exome sequencing identified a homozygous BRDT mutation in a patient with acephalic spermatozoa

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.